Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_assertion type Assertion NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_head.
- NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_assertion description "[Moreover, when a CCR4(+) Hodgkin's lymphoma cell line was inoculated s.c. into hu-HSC NOG-IL-2 Tg, the tumor growth was significantly suppressed by treatment with a therapeutic humanized anti-CCR4 Ab (mogamulizumab), suggesting that the human NK cells in the mice exerted active Ab-dependent cellular cytotoxicity in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_provenance.
- NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_assertion evidence source_evidence_literature NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_provenance.
- NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_assertion SIO_000772 25712215 NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_provenance.
- NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_assertion wasDerivedFrom befree-2016 NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_provenance.
- NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_assertion wasGeneratedBy ECO_0000203 NP1266064.RAxEyEQxxudltnSmh7xxgnsRKF5txHwdDrzMRkSctX6MI130_provenance.